This review illustrates how measurements of clinical status in patients with myasthenia gravis have evolved from clinical descriptions and estimates of mortality rates to more sophisticated evaluative instruments, including numerical rating scales that measure strength, endurance, quality of life, and activities of daily living. The rationale and use of weighting and the importance of patient-reported outcomes are also discussed. The measurement of the steroid-sparing effect of an immunosuppressant is also reviewed. Muscle Nerve 42: 5-13, 2010
机构:
Osaka Med Coll, Dept Internal Med 4, Div Neurol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, JapanOsaka Med Coll, Dept Internal Med 4, Div Neurol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan
Yoshimoto, Yukiyo
Ishida, Shimon
论文数: 0引用数: 0
h-index: 0
机构:
Osaka Med Coll, Dept Internal Med 4, Div Neurol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, JapanOsaka Med Coll, Dept Internal Med 4, Div Neurol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan
Ishida, Shimon
Hosokawa, Takafumi
论文数: 0引用数: 0
h-index: 0
机构:
Osaka Med Coll, Dept Internal Med 4, Div Neurol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, JapanOsaka Med Coll, Dept Internal Med 4, Div Neurol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan
Hosokawa, Takafumi
Arawaka, Shigeki
论文数: 0引用数: 0
h-index: 0
机构:
Osaka Med Coll, Dept Internal Med 4, Div Neurol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, JapanOsaka Med Coll, Dept Internal Med 4, Div Neurol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan